Skip to main content
. 2022 Feb 23;4:100073. doi: 10.1016/j.conx.2022.100073

Fig. 4.

Fig. 4

Cumulative distribution of MPA concentrations 4 months after a 104 mg subcutaneous injection (n = 95; left) and seven months after a 150 mg subcutaneous injection (n = 29; right), based on data from two trials conducted between 2015 and 2018 [10,11]. Dashed lines and 95% confidence bands are based on non-parametric maximum likelihood estimation. Solid curves are parametric model fits. Abbreviation: MPA, medroxyprogesterone acetate.